Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics
Margaret May(James Madison University), Jonathan A C Sterne(University of Bristol), Rodolphe Thiébaut(Université de Bordeaux), Amy C. Justice(Yale University), Ole Kirk(University of Copenhagen), Paz Sobrino‐Vegas, Robert S. Hogg(Simon Fraser University), Dominique Costagliola(Inserm), Jörg Janne Vehreschild(University Hospital Cologne), Fiona Lampe(University College London), Bryan E. Shepherd(Vanderbilt University), Jodie L. Guest(Emory University), Ard van Sighem(Stichting HIV Monitoring), Heidi M. Crane(University of Washington), M. John Gill(University of Calgary), Antonella d’Arminio Monforte(University of Milan), Suzanne M Ingle(University of Bristol), Gemma Navarro(Corporació Sanitària Parc Taulí), Bruno Ledergerber(University Hospital of Zurich), Michael S Saag(Harborview Medical Center)
Cited by 39
Related Papers
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
|The Lancet|2008|1.7k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k